Philippe Mendels-flandre
Founder of AUSTRAL Diagnostics
France
Overview
Work Experience
Co-founder & CEO
2022 - Current
Membre du Comité de Surveillance
2021
Business Angel
2017
Independent Board Member
2019 - 2022
General Manager France and Benelux
2018 - 2021
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Raised $2,430,652,943.00 from Blackstone Credit, Hayfin Capital Management, Silicon Valley Bank, Oxford Finance LLC and MidCap Financial.
Chief Operating Officer
2017 - 2018
Head of EAMEA Emerging Markets Cluster
2016 - 2017
VP Finance EMEA
2015 - 2016
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.
Bioscience Business Unit Director
2013 - 2015
P&L accountable for the Sales and Marketing Operations of the French Bioscience BU ($200mio turnover, 20 employees, $10mio spend) Achievements : - Budget exceeded in 2013 and 2014 (8% growth) - Reshaping of the organization and staffing up for future growth - Product launches preparation
Key Account Director France
2010 - 2013
Developed a team of 9 key account managers with ad hoc support aiming at enhancing customer experience and overall satisfaction. Implemented change management in the broad organisation to align on new commercial model.
Global Manufacturing Finance Director
2008 - 2010
Finance Director France
2005 - 2008
Advisor up-scale customers
1993 - 1995
Education
Applied Economics
1989 - 1992
Erasmus program
1991 - 1992